This cohort study assesses the prevalence of SARS-CoV-2–related conjunctival manifestations and conjunctival swab positivity on hospital admission and 3 days thereafter for patients not receiving anti-inflammatory treatment. Click to show full abstract
This cohort study assesses the prevalence of SARS-CoV-2–related conjunctival manifestations and conjunctival swab positivity on hospital admission and 3 days thereafter for patients not receiving anti-inflammatory treatment.
Keywords:
conjunctival manifestations;
term changes;
prevalence short;
sars cov;
short term
Journal Title: JAMA Network Open
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: JAMA Network Open
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!